Inspiremd (NYSEMKT:NSPR) Shorted Shares Increased 4.27% After Market Selling

July 18, 2017 - By Vivian Park

 Inspiremd (NYSEMKT:NSPR) Shorted Shares Increased 4.27% After Market Selling

The stock of Inspiremd (NYSEMKT:NSPR) registered an increase of 4.27% in short interest. NSPR’s total short interest was 552,200 shares in July as published by FINRA. Its up 4.27% from 529,600 shares, reported previously. With 121,500 shares average volume, it will take short sellers 5 days to cover their NSPR’s short positions.

It is 0.00% or $0 reaching $0.46 per share. It is down 94.59% since July 18, 2016 and is downtrending. It has underperformed by 111.29% the S&P500.

InspireMD, Inc. is a medical device company. The company has market cap of $3.46 million. The Firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. It currently has negative earnings. The Company’s MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures.

InspireMD Inc (NYSEMKT:NSPR) Ratings Coverage

Among 2 analysts covering InspireMD (NYSEMKT:NSPR), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. InspireMD had 2 analyst reports since January 7, 2016 according to SRatingsIntel. H.C. Wainwright initiated InspireMD Inc (NYSEMKT:NSPR) on Thursday, January 7 with “Buy” rating. Rodman & Renshaw initiated InspireMD Inc (NYSEMKT:NSPR) on Thursday, January 7 with “Buy” rating.

More notable recent InspireMD Inc (NYSEMKT:NSPR) news were published by: Marketwired.com which released: “InspireMD Announces Distribution Agreement for CGuard EPS in Taiwan” on June 08, 2017, also 247Wallst.com with their article: “Why InspireMD More Than Doubled” published on November 01, 2016, Finance.Yahoo.com published: “InspireMD Announces Listing of Series B Warrants on the NYSE MKT” on April 05, 2017. More interesting news about InspireMD Inc (NYSEMKT:NSPR) were released by: Seekingalpha.com and their article: “InspireMD: A Cure For The Broken Biotech Heart” published on October 16, 2013 as well as Marketwired.com‘s news article titled: “InspireMD Announces Distribution Agreement for CGuardâ„¢ EPS in Poland” with publication date: June 05, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.